Search results
Results From The WOW.Com Content Network
Cefovecin is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long ...
With new puppies come great responsibilities—like vaccines. Vaccinating your puppy protects them from getting and spreading seriously scary diseases. Of course, life with a rambunctious little ...
Juvenile cellulitis, also known as puppy strangles or juvenile pyoderma, is an uncommon disease of dogs. [1] Symptoms include dermatitis , lethargy , depression and lameness . When puppies are first presented with what appears to be staphylococcal pyoderma , juvenile cellulitis, a relatively rare condition, may not be considered.
Vaccination of dogs is the practice of animal vaccination applied to dogs. Programs in this field have contributed both to the health of dogs and to the public health . In countries where routine rabies vaccination of dogs is practiced, for example, rabies in humans is reduced to a very rare event.
Cavalier King Charles Spaniel with bandaged foot A dog's injured leg. The health of dogs is a well studied area in veterinary medicine.. Dog health is viewed holistically; it encompasses many different aspects, including disease processes, genetics, and nutritional health, for example.
Starting in 1881, dried spinal cord material from infected rabbits was given to dogs to inoculate them against rabies. [10] The infected nerve tissue was dried to weaken the virus. [11] Subsequently, in 1885, the vaccine was given to a 9-year-old boy infected with the rabies disease, Joseph Meister, who survived when no one had before. [10]
Download as PDF; Printable version; From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Vaccination of dogs; Retrieved from " ...
Pradofloxacin, sold under the brand name Veraflox among others, is a third-generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class. [5] It was developed by Elanco Animal Health GmbH and received approval from the European Commission in April 2011, for prescription-only use in veterinary medicine for the treatment of bacterial infections in dogs and cats.